Log In
Print
BCIQ
Print
Print this Print this
 

PureGraft

  Manage Alerts
Collapse Summary General Information
Company Cytori Therapeutics Inc.
DescriptionDevice which facilitates autologous adipose tissue transfer for aesthetic body
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentMarketed
Standard Indication Transplant (unspecified)
Indication DetailsPrepare autologous adipose tissue for transplant
Regulatory Designation

Partner

Bimini Technologies; Valeant Pharmaceuticals International Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today